IDT

Global PCIe Switches Market (2022 to 2027) - Featuring Arrow Electronics, Broadcom, Diodes and IDT Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 3, 2022
Technology, Semiconductor, Geography, Growth, Investment, Arrow Electronics, Emotion, Porter's five forces analysis, Electronics, CAGR, Industry, Texas Instruments, Toshiba, NXP Semiconductors, PCI-SIG, Ansoff Matrix, Global, Orion, COVID-19, USD, SWOT, Risk, Microchip Technology, IDT, Market development, Observation, Competitive analysis, Impact, Maxim Integrated, Pharmaceutical industry, Retail, Risk management, Semtech, Broadcom Inc.

The Global PCIe Switches Market is estimated to be USD 2.03 Bn in 2022 and is expected to reach USD 2.54 Bn by 2027, growing at a CAGR of 4.6%.

Key Points: 
  • The Global PCIe Switches Market is estimated to be USD 2.03 Bn in 2022 and is expected to reach USD 2.54 Bn by 2027, growing at a CAGR of 4.6%.
  • Market dynamics are forces that impact the prices and behaviors of the Global PCIe Switches Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global PCIe Switches Market.
  • The report offers a comprehensive evaluation of the Global PCIe Switches Market.

IDT Corporation to Present at LD Micro Main Event Investor Conference

Retrieved on: 
Monday, October 24, 2022
CA, Sale, SEC, Cloud communications, IDT Corporation, Family, NYSE, Intelligence, IDT, Judgement, NRS, IDT Global Israel, Private Securities Litigation Reform Act, Friends, Science and technology in Asia, GLOBE, SMS, Solution, Security (finance), Online shopping, Bank

NEWARK, NJ, Oct. 24, 2022 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, today announced that Shmuel Jonas, Chief Executive Officer, will present at the LD Micro Main Event XV investor conference on Tuesday, October 25, 2022 in Los Angeles, CA.

Key Points: 
  • NEWARK, NJ, Oct. 24, 2022 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, today announced that Shmuel Jonas, Chief Executive Officer, will present at the LD Micro Main Event XV investor conference on Tuesday, October 25, 2022 in Los Angeles, CA.
  • Those who wish to participate virtually or in person can register for the conference and live stream here: https://me22.sequireevents.com/ .
  • The presentation deck will also be available on the investor relations pages of the IDT Corporation website .
  • IDT Corporation (NYSE: IDT) is a global provider of fintech, cloud communications, and traditional communications services.

Pagaya Announces Timing of Third Quarter 2022 Earnings Release

Retrieved on: 
Wednesday, October 19, 2022
Banking, Professional Services, Finance, NASDAQ, API, IR, IDT, Machine learning, Ecosystem, Technology, Cryptocurrency

Pagaya Technologies (NASDAQ: PGY) intends to announce its third quarter 2022 earnings on November 10, 2022.

Key Points: 
  • Pagaya Technologies (NASDAQ: PGY) intends to announce its third quarter 2022 earnings on November 10, 2022.
  • A conference call to discuss those earnings will be held on the same day at 5:00 p.m.
  • Details to register for the live webcast presentation and dial-in information will be available on Pagayas IR website located at investor.pagaya.com.
  • Pagaya (NASDAQ: PGY) is a global technology company making life-changing financial products and services available to more people nationwide, as it reshapes the financial services ecosystem.

NRSInsights’ September Retail Same-Store Sales Report

Retrieved on: 
Friday, October 7, 2022
Commerce, Sale, SEC, Growth, IDT Corporation, POS, Convenience, NYSE, Data, Silliman, IDT, National Association, Judgement, NRS, SVP, Private Securities Litigation Reform Act, NACS, DMA's, CPG, Foodservice, GLOBE, Bodega, Tobacco, Grocery store, Online gambling, Cryptocurrency, Marketing, Online shopping

NEWARK, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) nationwide point-of-sale (POS) platform, today announced comparative same-store sales results for September 2022.

Key Points: 
  • NEWARK, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- NRSInsights , a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) nationwide point-of-sale (POS) platform, today announced comparative same-store sales results for September 2022.
  • Suzy Silliman, SVP, Data Strategy and Sales at NRS commented, NRS same-store sales data for September shows continued sequential weakening of consumer demand although sales remain well above the year-ago levels because of exceptionally strong demand earlier in the year.
  • The table below provides historical comparative data with the US Commerce Departments Advance Monthly Retail Trade data excluding food service:
    The NRSInsights monthly Same-Store Retail Sales Reports are intended to provide timely topline data reflective of sales at NRS network of independent, predominantly urban, retail stores.
  • Over the prior 12 months, the NRS same-store retail sales data has exhibited a statistically significant correlation with the US Commerce Departments Advance Monthly Retail Trade data excluding food services (r = .869, p = 0.00001)
    The NRSInsights data have not been adjusted to reflect inflation, demographic distributions, seasonal buying patterns, item substitution, or other factors that may facilitate comparisons to other periods, to other same-store retail sales data, or to the US Commerce Departments retail data.

Maravai LifeSciences Announces CEO Leadership Transition

Retrieved on: 
Monday, October 3, 2022
Vaccine, GLOBE, GTCR, NASDAQ, U.S. Securities and Exchange Commission, Gene editing, Research, Industry, Private Securities Litigation Reform Act, Danaher, Engineering, CEO, Integrated DNA Technologies, Genomic Medicine Institute, COVID-19, Annual report, Senior, Growth, Integration, RNA transfection, Partnership, Genomics, Â, SAN, Executive, Leadership, IDT, Acquisition, Danaher Corporation, Board of directors, The Conference Board, Biochemistry, University, Board, Marketing, Company, III, Management, Pharmaceutical industry, Security (finance), Melamaravakkadu

Maravais first CEO and co-founder Carl Hull will directly support Mr. Martin during this leadership transition and will remain with Maravai as Executive Chairman of the Board where he will continue to guide the companys long-term strategy.

Key Points: 
  • Maravais first CEO and co-founder Carl Hull will directly support Mr. Martin during this leadership transition and will remain with Maravai as Executive Chairman of the Board where he will continue to guide the companys long-term strategy.
  • Additionally, he has a stellar reputation for driving employee engagement and operational excellence, said Carl Hull, Executive Chairman of Maravai.
  • I want to commend Carl for his leadership and thank him and the Board for their confidence in me, said Trey Martin, CEO of Maravai.
  • His focus will also be on supporting Mr. Martin throughout this leadership transition and leveraging their complementary skillsets to further improve the business.

FormFactor Appoints New Board Member

Retrieved on: 
Monday, September 26, 2022
Director, Integrated Device Technology, Business administration, Deloitte, Notre Dame, IBM, Analog Devices, SOC, HGST, Industry, FORM, Nasdaq, Seattle University, Board of directors, IDT, Ambarella Inc., NASDAQ, Maxim Integrated, Board, Factor of safety, GLOBE, University, Certified Public Accountant, Management, Nvidia

LIVERMORE, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced the appointment of Brian White to its Board of Directors effective immediately.

Key Points: 
  • LIVERMORE, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced the appointment of Brian White to its Board of Directors effective immediately.
  • FormFactor is very fortunate to have Brian White join our Board of Directors.
  • I look forward to Brian's contributions as FormFactor continues to grow its leadership position in the semiconductor industry.
  • Mr. White joins the FormFactor Board of Directors with over 29 years of experience in the semiconductor and high-tech industries.

Integrated DNA Technologies Launches New PrimeTime™ qPCR One-Step Master Mix with Exclusive Mutant Enzyme

Retrieved on: 
Monday, September 26, 2022
Health, Genetics, Other Health, Other Science, Research, Science, YouTube, Workflow, Enzyme, RUO, Agriculture, Integrated DNA Technologies, Twitter, Molecular Inversion Probe, CRISPR, Master Mix, LinkedIn, RNA interference, Data analysis, Industry, Synthetic biology, Buffer, Cancer, VTM, Instagram, Pain, Prime time, Solution, Integration, IDT, Primer, RT, RNA, Research, Genomics, Multimedia, PCR, Triangle Park (Quezon City), Gene expression, GMP, ISO, Infection, Real-time, Fine chemical, Compact Disc, Facebook

To support the growing need for an inhibitor resistant, high-performance master mix that allows for direct amplification of crude samples, Integrated DNA Technologies has launched the PrimeTime 1-Step 4X Broad-Range qPCR Master Mix .

Key Points: 
  • To support the growing need for an inhibitor resistant, high-performance master mix that allows for direct amplification of crude samples, Integrated DNA Technologies has launched the PrimeTime 1-Step 4X Broad-Range qPCR Master Mix .
  • An inhibitor-resistant master mix was achieved through the discovery of enzymes engineered by IDT, one of which is exclusive to this master mix.
  • The addition of the PrimeTime 1-Step 4X Broad-Range qPCR Master Mix enhances IDTs existing portfolio of master mixes, enzymes, and reagents.
  • IDTs master mix offerings currently include the PrimeTime Gene Expression Master Mixa 2X solution for probe-based qPCR in two-step RT-PCR experimentsand the PrimeTime One-Step RT-qPCR Master Mix, a 2X solution for probe-based qPCR in one-step RT-qPCR experiments.

IDT Corporation to Report Fourth Quarter and Fiscal Year 2022 Results

Retrieved on: 
Wednesday, September 21, 2022
NYSE, Q&A, Sale, IDT Corporation, Cloud communications, IDT Global Israel, SMS, Intelligence, Solution, Science and technology in Asia, Friends, Family, IDT, NRS, GLOBE, Bank

NEWARK, NJ , Sept. 21, 2022 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, has scheduled its report of financial and operational results for the fourth quarter and fiscal year 2022 fiscal year (the three and twelve months ended July 31st) on Thursday, October 6, 2022.

Key Points: 
  • NEWARK, NJ , Sept. 21, 2022 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, has scheduled its report of financial and operational results for the fourth quarter and fiscal year 2022 fiscal year (the three and twelve months ended July 31st) on Thursday, October 6, 2022.
  • IDT will host an earnings conference call beginning at 5:30 PM Eastern with managements discussion of results, outlook, and strategy followed by Q&A with investors.
  • IDT Corporation (NYSE: IDT) is a global provider of fintech, cloud communications, and traditional communications services.
  • Our IDT Global and IDT Express wholesale offerings enable communications service enterprises to provision and manage international voice and SMS services.

BOSS Money and UBA Partner to Expand Remittance Options to Nigeria

Retrieved on: 
Monday, September 19, 2022
App store, United Bank, NYSE, Sale, App Store (iOS/iPadOS), IDT Corporation, Cloud communications, Judgement, Private Securities Litigation Reform Act, Partnership, IDT Global Israel, SMS, Intelligence, Science and technology in Asia, Friends, Family, IDT, US, Retail, UBA, NRS, GLOBE, SEC, BOSS, Financial services, Bank, Online shopping

Newark, NJ, Sept. 19, 2022 (GLOBE NEWSWIRE) -- BOSS Money, the money remittance and payments brand of IDT Corporation (NYSE: IDT), and Africa Global Bank (United Bank for Africa), a leading pan-African financial institution, today announced a collaboration to expand disbursement options for money transfers from the U.S. to Nigeria. The partnership will enable BOSS Money customers to send U.S. dollars for direct deposit at any of the approximately 20 million United Bank for Africa (UBA) accounts in Nigeria.

Key Points: 
  • The partnership will enable BOSS Money customers to send U.S. dollars for direct deposit at any of the approximately 20 million United Bank for Africa (UBA) accounts in Nigeria.
  • We are delighted to partner with UBA, a trusted leader in personal banking services, to power convenient, reliable, affordable, and timely money transfers to Nigeria.
  • Through the partnership, BOSS Money customers will be able to transfer up to US$100 to Nigeria for as little as US$3.99 or transfer up to US$2,999 for as little as US$6.99 when using the BOSS Money or BOSS Calling apps.
  • Our BOSS Money international money remittance and mobile top-up services offer convenient and reliable value transfers.

Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration

Retrieved on: 
Friday, September 16, 2022
Lyme disease, COVID-19, 1018, World, Severe acute respiratory syndrome coronavirus 2, World Health Organization, Vaccination, European Commission, Company, IDT Corporation, VLA, Vero, EU, History, Biosafety level, Technology, Vaccine, Nasdaq, IDT, Chikungunya, WHO, VLA2001, Marketing, CpG, Saint-Herblain, Euronext Paris, EMA, Infection, Kingdom

As per the commercial manufacturing services agreement signed in November 20211, IDT Biologika produced VLA2001 bulk vaccine at its Biosafety Level 3 facilities in Germany, and Valneva bought the batches that were manufactured so far by IDT.

Key Points: 
  • As per the commercial manufacturing services agreement signed in November 20211, IDT Biologika produced VLA2001 bulk vaccine at its Biosafety Level 3 facilities in Germany, and Valneva bought the batches that were manufactured so far by IDT.
  • Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
  • IDT Biologika is an innovative biotech company with a successful history dating back 100 years.
  • In the US, the IDT Corporation has a manufacturing site for clinical test samples in Rockville, Maryland.